SK14662003A3 - Použitie polyklonálnych imunoglobulínov - Google Patents

Použitie polyklonálnych imunoglobulínov Download PDF

Info

Publication number
SK14662003A3
SK14662003A3 SK1466-2003A SK14662003A SK14662003A3 SK 14662003 A3 SK14662003 A3 SK 14662003A3 SK 14662003 A SK14662003 A SK 14662003A SK 14662003 A3 SK14662003 A3 SK 14662003A3
Authority
SK
Slovakia
Prior art keywords
antibodies
immunization
immunoglobulin
vaccine
polyclonal
Prior art date
Application number
SK1466-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Hans Loibner
Gottfried Himmler
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag filed Critical Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag
Publication of SK14662003A3 publication Critical patent/SK14662003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK1466-2003A 2001-06-01 2002-03-19 Použitie polyklonálnych imunoglobulínov SK14662003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0086001A AT410637B (de) 2001-06-01 2001-06-01 Verwendung von polyklonalen immunglobulinen
PCT/AT2002/000088 WO2002096455A2 (de) 2001-06-01 2002-03-19 Verwendung von polyklonalen immunglobulinen als impfstoff

Publications (1)

Publication Number Publication Date
SK14662003A3 true SK14662003A3 (sk) 2004-05-04

Family

ID=3682339

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1466-2003A SK14662003A3 (sk) 2001-06-01 2002-03-19 Použitie polyklonálnych imunoglobulínov

Country Status (16)

Country Link
US (1) US20040151717A1 (cs)
EP (1) EP1399185A2 (cs)
JP (1) JP2004532261A (cs)
CN (1) CN1512895A (cs)
AT (1) AT410637B (cs)
AU (1) AU2002242447B2 (cs)
BR (1) BR0210239A (cs)
CA (1) CA2449026A1 (cs)
CZ (1) CZ20033273A3 (cs)
HU (1) HUP0400031A3 (cs)
IL (2) IL158950A0 (cs)
MX (1) MXPA03010829A (cs)
NO (1) NO20035282L (cs)
PL (1) PL367835A1 (cs)
SK (1) SK14662003A3 (cs)
WO (1) WO2002096455A2 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10127712A1 (de) * 2001-06-07 2002-12-19 Torsten Witte Anwendung von IgM-Antikörpern gegen dsDNA beim systemischen Lupus erythematodes mit Nephritis
WO2005023867A1 (en) * 2003-09-08 2005-03-17 Medical Research Council Method for the treatment or prophylaxis of tuberculosis
ES2988823T3 (es) * 2014-12-03 2024-11-21 Csl Behring Ag Producto farmacéutico con mayor estabilidad que comprende inmunoglobulinas
FR3072880A1 (fr) * 2017-10-30 2019-05-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Formulation liposomale et son utilisation en therapie anti-tumorale

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3340487A1 (de) * 1983-11-09 1985-05-15 Sandoz-Patent-GmbH, 7850 Lörrach Neue therapeutische verwendung
EP0438803B1 (en) * 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccines against cancer and infectious diseases
JP2795289B2 (ja) * 1990-09-04 1998-09-10 富士通株式会社 電子機器におけるプリント板ユニットの保持構造
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
WO1992015885A1 (en) * 1991-03-11 1992-09-17 Idec Pharmaceuticals Corporation Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
US6462187B1 (en) * 2000-06-15 2002-10-08 Millennium Pharmaceuticals, Inc. 22109, a novel human thioredoxin family member and uses thereof
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma
AT409086B (de) * 1999-11-16 2002-05-27 Igeneon Krebs Immuntherapie Neue verwendung von antikörpern als impfstoffe
AT410636B (de) * 2001-03-23 2003-06-25 Igeneon Krebs Immuntherapie Verfahren zur herstellung eines impfstoffes

Also Published As

Publication number Publication date
NO20035282D0 (no) 2003-11-27
HUP0400031A2 (hu) 2004-04-28
US20040151717A1 (en) 2004-08-05
MXPA03010829A (es) 2004-02-17
ATA8602001A (de) 2002-11-15
CA2449026A1 (en) 2002-12-05
WO2002096455A3 (de) 2003-12-24
AU2002242447B2 (en) 2007-11-08
CN1512895A (zh) 2004-07-14
EP1399185A2 (de) 2004-03-24
BR0210239A (pt) 2004-03-30
HUP0400031A3 (en) 2006-03-28
JP2004532261A (ja) 2004-10-21
IL158950A0 (en) 2004-05-12
PL367835A1 (en) 2005-03-07
AT410637B (de) 2003-06-25
CZ20033273A3 (en) 2004-07-14
WO2002096455A2 (de) 2002-12-05
NO20035282L (no) 2003-11-27
IL158950A (en) 2008-04-13

Similar Documents

Publication Publication Date Title
US8444974B2 (en) Use of antibodies for the vaccination against cancer
Díaz et al. Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides
JPH08511015A (ja) 治療用抗体断片
EP2838919A1 (en) Anti-mige antibodies that bind to the junction between ch4 and c epsilon mx domains
AU780853B2 (en) Use of anti-idiotypical antibodies as vaccines against cancer
Manheimer et al. Anti-immunoglobulin antibodies. V. Age-dependent variation of clones stimulated by polysaccharide TI-2 antigens in 129 and MRL mice spontaneously producing anti-gamma-globulin antibodies.
Roehnisch et al. Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model
SK14662003A3 (sk) Použitie polyklonálnych imunoglobulínov
SK11732003A3 (sk) Spôsob výroby očkovacej látky
EP0211368B1 (en) Monoclonal anti-asialo GM1 antibody
Rombach et al. Induction of an anti-Fab, anti-DNA and anti-RNA polymerase I autoantibody response network in rabbits immunized with SLE anti-DNA antibody
US20040265318A1 (en) Use of antibodies for the vaccination against cancer
US20060018901A1 (en) Use of antibodies in a very low dose for the vaccination against cancer
Haba et al. Mechanisms of induction of tolerance to syngeneic IgE
Lu et al. Roles of accessory molecules in processing and presentation of foreign antigens
JPH06508829A (ja) サプレッサーｔ細胞ハイブリドーマ
CZ20032573A3 (cs) Způsob výroby očkovací látky
Weigle Autoimmune Processes Resulting from
JPWO2001066141A1 (ja) 抗リン脂質抗体症候群の治療剤及び予防剤
WO2001066141A1 (fr) Agents therapeutiques et prophylactiques diriges contre le syndrome des antiphospholipides

Legal Events

Date Code Title Description
FC9A Refused patent application